Bill Martin
Advertisement
Articles by Bill Martin
Here are key factors that significantly impact the marketplace and are gathering high levels of attention today in the diverse world of specialty pharmacy.
Advertisement
Latest Updated Articles
- Biosimilars: Could This Be a Pearl in the Patient Protection and Affordable Care Act?
Published: October 12th 2010 | Updated:
- 8 Mega Trends Shaping the Future of Specialty Pharmacy
Published: December 5th 2011 | Updated:
- Biosimilars: Could This Be a Pearl in the Patient Protection and Affordable Care Act?
Published: February 10th 2012 | Updated:
- Eight Mega Trends Shaping the Future of Specialty Pharmacy
Published: September 12th 2011 | Updated:
Advertisement
Advertisement
Trending on Pharmacy Times
1
FDA Approves Daratumumab and Hyaluronidase-fihj With Quadruplet Regimen for Newly Diagnosed Multiple Myeloma
2
FDA Expanded Approval of Imiglucerase Expands Treatment Options for Type 3 Gaucher Disease
3
Study Finds No Evidence That Hormone Therapy Use Affects Dementia Risk in Postmenopausal Women
4
FDA Draft Guidance Signals Shift Toward MRD, Complete Response as Accelerated Approval End Points in Multiple Myeloma
5